Authors: Megha, Monika Yadav, Nitika Dhaka, Nikita Kadian, Krishna Kant Sharma, Dr. Rajeev Kumar Kapoor
Abstract
Technology Area
Nanotechnology; Green Nanobiotechnology; Microbial/Mushroom-based Bioprocessing; Biomedical Applications
Technology
The present technology involves the green synthesis of silver (AgNPs) and iron nanoparticles (FeNPs) using extracellular extracts of Pleurotuscitrinopileatus and Ganoderma spp. The process utilizes mushroom-derived biomolecules as natural reducing and stabilizing agents, eliminating the need for toxic chemicals. The synthesis is simple, cost-effective, and environmentally sustainable, indicated by a characteristic color change due to reduction of metal ions. The nanoparticles are characterized using standard analytical techniques such as UV–Visible spectroscopy (peak at 425 nm for AgNPs), FTIR, SEM, and zeta potential analysis. The synthesized nanoparticles exhibit significant antibacterial, antifungal, and antioxidant activities, making them suitable for biomedical and environmental applications.
Potential Market / Customers
Pharmaceutical and biomedical industries (antimicrobial formulations, wound dressings), Healthcare sector (infection control, coatings, therapeutics), Food industry (food preservation and packaging), Water treatment and environmental remediation industries, Cosmetic industry (antioxidant-based products), Research and nanotechnology companies
Technology Valuation (Commercial Potential & Value Proposition)
This technology offers strong commercial potential due to its eco-friendly, scalable, and low-cost
production process compared to conventional nanoparticle synthesis methods. The use of readily
available mushroom biomass reduces production costs and enhances sustainability.
